Skip to main content
. 2015 Apr 30:287–298. [Article in German] doi: 10.1007/978-3-662-46500-4_20
Erreger Therapieoption
MRSA

Linezolid

Vancomycin ± Rifampicin oder ± Fosfomycin

ESBL-positive Enterobacteriaceae Carbapeneme
Acinetobacter spp. Imipenem, Meropenem, bei Resistenz Colistin ± Tigecyclin
Stenotrophomonas maltophilia Cotrimoxazol, Levofloxacin

MBL-positive Enterobacteriaceae

MBL-positive Acinetobacter

Colistin ± Tigecyclin
MBL-positive P. aeruginosa Colistin